YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
WESTBROOK, Maine, October 01, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026,…
Transaction marks the first realization from the now closed specialist animal health fund's inaugural vehicle CHICAGO, Sept. 30, 2026 /PRNewswire/ -- Chicago Pacific Founders ("CPF") today announced the exit of its investment in CoVetAI In…
Company Logo The companion animal diagnostics market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, registering an 8.7% CAGR. Growth is driven by rising pet healthcare spending, preventive care, chronic and…
IDEXX Laboratories, Inc. IDXX is strengthening its Companion Animal Group ("CAG") business through recurring revenue growth, wider customer adoption and expanding diagnostic offerings. Software adoption continues to expand, with recurring…
Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reaffirmed its long-term growth targets of more than 10% organic revenue growth and more than 15% EPS growth, supported by recurring-revenue mome…
Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reaffirmed its long-term growth outlook, targeting more than 10% organic growth and more than 15% EPS growth, supported by veterinary diagnostic…
On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done. It sounds like a productivity gadge…
IDEXX Laboratories has seen a mixed share price story in recent years, and the question now is whether its current US$506.48 level lines up with the cash flows the business may generate over time. Recent price pressure and fresh AI-driven…
IDEXX Laboratories (IDXX) drew fresh attention after expanding its Faecal Dx antigen testing platform in the United Kingdom to cover taeniid tapeworms, including Taenia and Echinococcus species, during routine veterinary visits. Recent mov…
IDEXX Laboratories, Inc. IDXX recently announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. The acquisition of CoV…
IDEXX Laboratories recently expanded its Faecal Dx antigen testing platform in the United Kingdom to include taeniid tapeworm detection, broadening routine intestinal parasite screening to seven clinically relevant parasite groups and trig…
Expanded testing menu now detects more intestinal parasites during routine visits WESTBROOK, Maine, September 17, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced…
[IDEXX Laboratories offices in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images IDEXX Laboratories (IDXX [https://seekingalpha.com/symbol/IDXX]) has acquired [https://seekingalpha.com/pr/20653060-idexx-laboratories-acqu…
Acquisition strengthens IDEXX's connected diagnostic and software ecosystem with AI-native workflow capabilities that enhance efficiency, clinical decision-making, and diagnostic utilization WESTBROOK, Maine, September 16, 2026--(BUSINESS…
Photo by Pexels on Pixabay If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying repla…
IDEXX sign at their offices in Silicon Valley_ By Sundry Photography IDEXX Laboratories, Inc. (IDXX) is a leading animal-health diagnostics and technology company best known for providing veterinarians with diagnostic testing, laboratory s…
WESTBROOK, Maine, August 31, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Execu…
IDEXX sign at their offices in Silicon Valley_ By Sundry Photography Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) is a global leader in animal health diagnostics, providing the tools and technology veterinarians rely on to diagno…
IDEXX Laboratories, Inc. IDXX is expanding its global commercial capabilities to support continued growth in the CAG Diagnostics recurring revenue stream. The company's software ecosystem remains a key pillar of its value proposition. Howe…
Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Focused Growth Fund". A copy of the letter can be downloaded here. In the second quarter, the Baron Focused Growth Fund achieved a 13.26%…
IDEXX Laboratories, Inc. IDXX paired a second-quarter earnings beat with faster recurring diagnostics growth, wider margins and a higher 2026 earnings outlook. The results show operating momentum holding up even as U.S. veterinary traffic…
IDEXX Laboratories IDXX is balancing durable diagnostic growth, improving profitability and a broad innovation cycle against a valuation that remains well above major benchmarks. The operating picture is favorable, but the stock still requ…
Wall Street ended lower Friday as investors took a pause following the S&P 500’s latest record high, capping a week that saw strength spread across technology, software, small caps, and commodities. The technology-heavy Nasdaq Composite de…
IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proB…
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full…
New test brings quantitative cardiac assessment for cats and dogs into everyday workflows WESTBROOK, Maine, August 11, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today anno…
[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. M…
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can…
IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap…
This article first appeared on GuruFocus. Revenue: Increased approximately 10% as reported and 9% organically. CAG Diagnostics Recurring Revenue: Grew 10.3% organically, with double-digit gains in both the US and international regions. US…
Earnings Call Insights: IDEXX Laboratories (IDXX) Q2 2026 MANAGEMENT VIEW * Andrew Emerson (Executive VP, CFO & Treasurer) said IDEXX delivered “approximately 10%” reported revenue growth and “9%” organic growth, driven by “over 10% organi…
Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. IDEXX reported strong Q2 performance, with revenue up approximately 10% reported and 9% organically, while EPS rose 18% to $4.27. Companion animal diag…
IDEXX Laboratories, Inc. IDXX reported second-quarter 2026 earnings of $4.27 per share, up 18% year over year. The figure surpassed the Zacks Consensus Estimate by 8.1%. Comparable constant-currency EPS of $4.07 improved 15% year over year…
Idexx Laboratories (IDXX) reported $1.22 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 9.7%. EPS of $4.27 for the same period compares to $3.63 a year ago. The reported revenue represents a s…
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively trad PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
BOSTON, Aug. 4, 2026 /PRNewswire/ -- The 180 MW Phase II portion of the Millers Branch Solar Facility in Haskell County, Texas has achieved commercial operation. The capacity was contracted through Sustainability Roundtable, Inc's Net Zero…